ZYROTRAM Injection is contraindicated: In patients who have previously shown hypersensitivity to the active substance.
In patients suffering from acute intoxication with alcohol, hypnotics, analgesics, opioids, or psychotropic medicinal products.
In patients who are receiving monoamine oxidase (MAO) inhibitors or who have taken them within the last 14 days.
In patients with epilepsy not adequately controlled by treatment.
For use in narcotic withdrawal treatment.
Children younger than 18 years to treat pain after surgery to remove the tonsils and/or adenoids.
Adolescents between 12 and 18 years who are obese or have conditions such as obstructive sleep apnea or severe lung disease, which may increase the risk of serious breathing problems.